Logo image of DCT

Duck Creek Technologies Inc (DCT) Stock Fundamental Analysis

USA - NASDAQ:DCT - US2641201064 - Common Stock

18.99 USD
0 (0%)
Last: 3/29/2023, 8:01:09 PM
18.99 USD
0 (0%)
After Hours: 3/29/2023, 8:01:09 PM
Fundamental Rating

4

DCT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. While DCT has a great health rating, there are worries on its profitability. DCT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DCT was profitable.
DCT had a positive operating cash flow in the past year.
In the past 5 years DCT always reported negative net income.
Of the past 5 years DCT 4 years had a positive operating cash flow.
DCT Yearly Net Income VS EBIT VS OCF VS FCFDCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

1.2 Ratios

DCT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCT Yearly ROA, ROE, ROICDCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 -1 -2 -3 -4

1.3 Margins

Looking at the Gross Margin, with a value of 56.63%, DCT is doing worse than 63.00% of the companies in the same industry.
In the last couple of years the Gross Margin of DCT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for DCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
DCT Yearly Profit, Operating, Gross MarginsDCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 40

More info and screens

8

2. Health

2.1 Basic Checks

DCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCT has more shares outstanding
DCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DCT Yearly Shares OutstandingDCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
DCT Yearly Total Debt VS Total AssetsDCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

DCT has an Altman-Z score of 15.48. This indicates that DCT is financially healthy and has little risk of bankruptcy at the moment.
DCT has a better Altman-Z score (15.48) than 95.33% of its industry peers.
DCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.48
ROIC/WACCN/A
WACC12.39%
DCT Yearly LT Debt VS Equity VS FCFDCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.68 indicates that DCT has no problem at all paying its short term obligations.
DCT's Current ratio of 4.68 is amongst the best of the industry. DCT outperforms 85.00% of its industry peers.
A Quick Ratio of 4.68 indicates that DCT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.68, DCT belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.68
DCT Yearly Current Assets VS Current LiabilitesDCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

DCT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
DCT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.81%.
The Revenue has been growing by 14.09% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%

3.2 Future

The Earnings Per Share is expected to grow by 29.83% on average over the next years. This is a very strong growth
DCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.02% yearly.
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DCT Yearly Revenue VS EstimatesDCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DCT Yearly EPS VS EstimatesDCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 0.05 0.1 0.15 0.2 0.25

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

DCT is valuated quite expensively with a Price/Earnings ratio of 189.90.
The rest of the industry has a similar Price/Earnings ratio as DCT.
DCT is valuated expensively when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 96.14, DCT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCT is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, DCT is valued quite expensively.
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
DCT Price Earnings VS Forward Price EarningsDCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

65.00% of the companies in the same industry are more expensive than DCT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DCT is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 101.39
EV/EBITDA 244.38
DCT Per share dataDCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DCT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as DCT's earnings are expected to grow with 29.83% in the coming years.
PEG (NY)9
PEG (5Y)N/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.26%, DCT has a reasonable but not impressive dividend return.
DCT's Dividend Yield is rather good when compared to the industry average which is at 36.72. DCT pays more dividend than 86.00% of the companies in the same industry.
With a Dividend Yield of 1.26, DCT pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

DCT has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DCT Yearly Dividends per shareDCT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y28.3%
EPS Next 3Y29.83%
DCT Yearly Income VS Free CF VS DividendDCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

More info and screens

Duck Creek Technologies Inc

NASDAQ:DCT (3/29/2023, 8:01:09 PM)

After market: 18.99 0 (0%)

18.99

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-29 2023-03-29/amc
Earnings (Next)06-27 2023-06-27/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.33%
Ins Owner Change0%
Market Cap2.52B
Analysts46.67
Price Target16.47 (-13.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)687.25%
Min EPS beat(2)67.06%
Max EPS beat(2)1307.44%
EPS beat(4)3
Avg EPS beat(4)570.06%
Min EPS beat(4)67.06%
Max EPS beat(4)1307.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.54%
Min Revenue beat(2)4.14%
Max Revenue beat(2)8.94%
Revenue beat(4)3
Avg Revenue beat(4)4.16%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)8.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)5.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.62%
EPS NY rev (1m)0%
EPS NY rev (3m)18.92%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 189.9
Fwd PE 96.14
P/S 8.14
P/FCF 101.39
P/OCF 85.71
P/B 3.45
P/tB 8.57
EV/EBITDA 244.38
EPS(TTM)0.1
EY0.53%
EPS(NY)0.2
Fwd EY1.04%
FCF(TTM)0.19
FCFY0.99%
OCF(TTM)0.22
OCFY1.17%
SpS2.33
BVpS5.5
TBVpS2.22
PEG (NY)9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.63%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5Y-0.64%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.72%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.68
Altman-Z 15.48
F-Score5
WACC12.39%
ROIC/WACCN/A
Cap/Depr(3y)19.14%
Cap/Depr(5y)28.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y21.11%
EPS Next 2Y28.3%
EPS Next 3Y29.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.81%
Revenue growth 3Y20.93%
Revenue growth 5Y14.09%
Sales Q2Q%9.76%
Revenue Next Year13.08%
Revenue Next 2Y12.42%
Revenue Next 3Y14.02%
Revenue Next 5YN/A
EBIT growth 1Y-38.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.99%
EBIT Next 3Y42.3%
EBIT Next 5YN/A
FCF growth 1Y269.82%
FCF growth 3Y5.03%
FCF growth 5YN/A
OCF growth 1Y151.66%
OCF growth 3Y-10.23%
OCF growth 5YN/A